摘要
目的研究通心络对急性脑梗死患者血清C-反应蛋白(CRP)的影响。方法43例急性脑梗死患者,随机分为常规治疗组和通心络治疗组,观察治疗1个月后血清CRP的变化。结果治疗1个月后,通心络治疗组血清CRP水平较常规治疗组明显下降(P<0.01)。结论通心络可抑制急性脑梗死后炎症反应,是治疗急性脑梗死的有效药物。
Objective To investigate the effect of Tongxinluo on the C-reactive protein(CRP) in patients with acute cerebral infarction.Methods 43 patients with acute cerebral infarction were divided into control group and Tongxinluo treatment group randomly,changes of serum CRP were observed after treatment of 1 month. Results After treating 1 month,compared with control group,serum CRP obviously decreased in Tongxinluo treatment group(P<0.01)Conclusion Tongxinluo capsule can inhibit the inflammation after acute cerebral infarction,which is effective in treating patients with acute cerebral infarction.
